Lansoprazole and Esomeprazole in Symptomatic GERDA Double-Blind, Randomised, Multicentre Trial in 3000 Patients Confirms Comparable Symptom Relief

被引：0
|
作者：
William Chey
Bidan Huang
Robert L. Jackson
机构：
[1] University of Michigan Health System,
[2] Abbott Laboratories,undefined
[3] TAP Pharmaceutical Products Inc.,undefined
[4] University of Michigan Hosptial,undefined
[5] 3912 Taubman Center,undefined
来源：
Clinical Drug Investigation | 2003年 / 23卷
关键词：
Lansoprazole; Esomeprazole; GERD Symptom; Erosive Oesophagitis; Interactive Voice Response System;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：69 / 84
页数：15
相关论文
共 50 条
  • [21] Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial
    Subtil, Damien
    Brabant, Gilles
    Tilloy, Emma
    Devos, Patrick
    Canis, Frederique
    Fruchart, Annie
    Bissinger, Marie-Christine
    Dugimont, Jean-Charles
    Nolf, Catherine
    Hacot, Christophe
    Gautier, Sophie
    Chantrel, Jerome
    Jousse, Marielle
    Desseauve, David
    Plennevaux, Jean Louis
    Delaeter, Christine
    Deghilage, Sylvie
    Personne, Anne
    Joyez, Emmanuelle
    Guinard, Elisabeth
    Kipnis, Eric
    Faure, Karine
    Grandbastien, Bruno
    Ancel, Pierre-Yves
    Goffinet, Francois
    Dessein, Rodrigue
    LANCET, 2018, 392 (10160): : 2171 - 2179
  • [22] The effect of adding duloxetine to lansoprazole on symptom and quality of life improvement in patients with gastroesophageal reflux diseases: A randomized double-blind clinical trial
    Mokhtare, Marjan
    Chaharmahali, Arezoo
    Bahardoust, Mansour
    Ghanbari, Atefeh
    Sarveazad, Arash
    Naghshin, Roozbeh
    Abbaskhanidavanloo, Farbod
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01):
  • [23] Esomeprazole for treatment of unexplained chest pain in primary care: A prospective, randomised, double-blind, placebo-controlled multicentre study
    Flook, N.
    Moayyedi, P.
    Dent, J.
    Talley, N. J.
    Persson, T.
    Karlson, B.
    Ruth, M.
    GUT, 2007, 56 : A42 - A42
  • [24] Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
    Fennell, Dean A.
    Ewings, Sean
    Ottensmeier, Christian
    Califano, Raffaele
    Hanna, Gerard G.
    Hill, Kayleigh
    Danson, Sarah
    Steele, Nicola
    Nye, Mavis
    Johnson, Lucy
    Lord, Joanne
    Middleton, Calley
    Szlosarek, Peter
    Chan, Sam
    Gaba, Aarti
    Darlison, Liz
    Wells-Jordan, Peter
    Richards, Cathy
    Poile, Charlotte
    Lester, Jason F.
    Griffiths, Gareth
    LANCET ONCOLOGY, 2021, 22 (11): : 1530 - 1540
  • [25] Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
    Hughes, Richard
    Dalakas, Marinos C.
    Merkies, Ingemar
    Latov, Norman
    Leger, Jean-Marc
    Nobile-Orazio, Eduardo
    Sobue, Gen
    Genge, Angela
    Cornblath, David
    Merschhemke, Martin
    Ervin, Carolyn Marie
    Agoropoulou, Catherine
    Hartung, Hans-Peter
    LANCET NEUROLOGY, 2018, 17 (08): : 689 - 698
  • [26] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
    Dogar, Omara
    Keding, Ada
    Gabe, Rhian
    Marshall, Anna-Marie
    Huque, Rumana
    Barua, Deepa
    Fatima, Razia
    Khan, Amina
    Zahid, Raana
    Mansoor, Sonia
    Kotz, Daniel
    Boeckmann, Melanie
    Elsey, Helen
    Kralikova, Eva
    Parrott, Steve
    Li, Jinshuo
    Readshaw, Anne
    Sheikh, Aziz
    Siddiqi, Kamran
    LANCET GLOBAL HEALTH, 2020, 8 (11): : E1408 - E1417
  • [27] Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial
    Chang, Anne B.
    Yerkovich, Stephanie T.
    Baines, Katherine J.
    Burr, Lucy
    Champion, Anita
    Chatfield, Mark D.
    Eg, Kah P.
    Goyal, Vikas
    Marsh, Robyn L.
    McCallum, Gabrielle B.
    McElrea, Margaret
    McPhail, Steven
    Morgan, Lucy C.
    Morris, Peter S.
    Nathan, Anne M.
    O'Farrell, Hannah
    Sanchez, Marion O.
    Parsons, Marianne
    Schultz, Andre
    Torzillo, Paul J.
    West, Nicholas P.
    Versteegh, Lesley
    Marchant, Julie M.
    Grimwood, Keith
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [28] Pramipexole in peritoneal dialysis patients with restless legs syndrome (RLS): a protocol for a multicentre double-blind randomised controlled trial
    Ma, Tian-tian
    Yang, Zhikai
    Zhu, Sainan
    Zhao, Jing-hong
    Li, Yi
    Sun, Fu-yun
    Zhao, Nan
    Xiong, Zu-ying
    Xiong, Zi-bo
    Dong, Jie
    BMJ OPEN, 2020, 10 (02):
  • [29] Efficacy and tolerability of metoprolol tartrate in patients with mild-to-moderate essential hypertension - A randomised, double-blind, multicentre trial
    Koenig, W
    CLINICAL DRUG INVESTIGATION, 2001, 21 (09) : 613 - 619
  • [30] Effect of chondroitin sulphate in symptomatic knee osteoarthritis:: a multicentre, randomised, double-blind, placebo-controlled study
    Mazieres, Bernard
    Hucher, Michel
    Zaim, Mohammed
    Garnero, Patrick
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (05) : 639 - 645
12345